Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb Co shares valued at $38,930 were sold by Holzer Phil M on Nov 04 ’24. At $55.62 per share, Holzer Phil M sold 700 shares. The insider’s holdings dropped to 11,760 shares worth approximately $0.69 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hirawat Samit purchased 1,830 shares, netting a total of over 100,055 in proceeds. Following the buying of shares at $54.67 each, the insider now holds 62,109 shares.
Before that, Holzer Phil M had added 700 shares to its account. In a trade valued at $38,930, the Officer bought Bristol-Myers Squibb Co shares for $55.62 each.
As published in a research note from Daiwa Securities on November 13, 2024, Bristol-Myers Squibb Co [BMY] has been rated up from a Neutral to an Outperform. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid November. As of October 25, 2024, Citigroup has decreased its “Buy” rating to a “Neutral” for BMY. Earlier on October 17, 2024, Bernstein initiated its rating. Their recommendation was “a Mkt perform” for BMY stock.
Analyzing BMY Stock Performance
During the last five days, there has been a surge of approximately 5.66%. Over the course of the year, Bristol-Myers Squibb Co shares have jumped approximately 13.84%. Shares of the company reached a 52-week high of $61.08 on 11/11/24 and a 52-week low of $39.35 on 07/05/24. A 50-day SMA is recorded $52.41, while a 200-day SMA reached $48.22. Nevertheless, trading volume fell to 10.8 million shares from 15.14 million shares the previous day.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
According to the 24-hour chart, there is a support level at 57.67, which, if violated, would cause prices to drop to 56.93. In the upper region, resistance lies at 59.32. The next price resistance is at 60.23. RSI (Relative Strength Index) is 64.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.90, which suggests the price will increase in the coming days. Percent R is at 28.80%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
